Public health officials are closely monitoring the latest bird flu outbreak that has sickened or killed millions of birds, ...

A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report today in ...

The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...

Sec. Mike Naig says the U.S. government is using what he describes as a three-legged stool approach to address the virus in ...

The antibody targets a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.

All nine macaques given the control developed severe disease when exposed to bird flu, as did all given the smallest dose of ...

Health authorities need to be concerned about bird flu, but the risk to the public is low. You’re reading The Checkup With Dr ...

Experts say the decision comes down to risk, and currently, the risk of H5N1 remains low. Rolling out a vaccine to farm workers and others at higher risk of infection would be a more targeted ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

To address the rising bird flu cases, the US government has committed $590 million to fast-track Moderna's mRNA bird flu ...

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...